Billets de Michelle Dawson

Billet publié sur Twitter/X le 13/04/2022 04:46

Retour aux billets Billet précédent Billet suivant
Twitter/X Essai clinique clinicaltrials.gov Extrait cité dans le billet Lien intégré au billet Termes sur l’autisme
Ouvrir le billet original

Infos sur le lien intégré au billet

Essai clinique

Guangzhou Women and Children's Medical Center (2018). Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder. ClinicalTrials.gov. Guangzhou Women and Children's Medical Center.

Plus d’infos

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

Guangzhou Women and Children's Medical Center (2018). Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder. ClinicalTrials.gov. Guangzhou Women and Children's Medical Center.

Date de publication
20/01/2018
Identifiant
NCT03434366
Auteurs
Guangzhou Women and Children's Medical Center
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
Guangzhou Women and Children's Medical Center
Source de métadonnées
clinicaltrials.gov

Résumé

Autism spectrum disorder (ASD) is a life-long neurodevelopmental disorder characterized by qualitative abnormalities in reciprocal social interactions and patterns of communication, and by a restricted, stereotyped, repetitive repertoire of interests and activities. The use of medications in adolescents and young adults with ASD is extremely common. However, few data address the effectiveness and harms of medications specifically in this population. The purpose of the study is to determine the efficacy and safety of intranasal ketamine with dexmedetomidine in children with ASD.

Ouvrir la source Lien vers la source citée